We have attached herewith Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. Kindly take the same on your record. Thank you.

October 29, 2026 To, To, Listing Department, The National Stock Exchange of India BSE Limited Ltd. Phiroze Jeejeebhoy Towers, The Listing Department Dalal Street, Exchange Plaza, Mumbai – 400 001 Bandra – Kurla Complex, Ref: BSE Scrip Code: 544497 Mumbai – 400051, NSE Scrip Code: AHCL Sub: Outcome of Board Meeting of ANLON HEALTHCARE LIMITED (“Company”) Respected Sir/Madam, Pursuant to Regulation 30 read with Part - A of Schedule III of SEBI Listing Regulations, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., Thursday, October 29, 2026 at the Registered Office of the Company inter alia considered and approved the following matters: 1. Unaudited Standalone and Consolidated Financial Results of the Company as set out in compliance with Indian Accounting Standards ("IND AS") for the quarter and half year ended September 30, 2026; together with the Limited Review Report of the Auditor's thereon. (Enclosed herewith) Meeting commenced on 03:00 p.m. IST and concluded on 04:00 p.m. IST. You are requested to take the above information on your record. Thanking You. For ANLON HEALTHCARE LIMITED PUNITKUMAR RASADIA MANAGING DIRECTOR DIN: 06696258 ANLON HEALTHCARE LIMITED CIN No.: L24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot- 360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in